Bosulif and Klor-con drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bosulif (bosutinib) and Klor-con (potassium chloride). Common drug interactions include nausea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Bosulif and Klor-con. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Bosulif?

Bosulif has active ingredients of bosutinib. eHealthMe is studying from 9,401 Bosulif users. Check the latest studies of Bosulif.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.



On Aug, 04, 2026

34 people who take Bosulif and Klor-con together, and have interactions are studied.

Bosulif and Klor-con drug interactions.

What are the common drug interactions of Bosulif and Klor-Con, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Fatigue (feeling of tiredness)
  4. Headache (pain in head)
  5. Rash
  6. Vomiting
  7. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  8. Abdominal pain upper
  9. Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
  10. Constipation

male:

  1. Diarrhoea
  2. Back pain
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Depression
  5. Essential hypertension (primary hypertension)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Headache (pain in head)
  8. Asthenia (weakness)
  9. Body temperature increased
  10. Bone pain

What are the common drug interactions of Bosulif and Klor-Con, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Head discomfort
  2. Headache (pain in head)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Inflammatory pain
  5. Nausea (feeling of having an urge to vomit)
  6. Pain in extremity
  7. Red blood cell sedimentation rate increased

50-59:

  1. Abdominal pain upper
  2. Constipation
  3. Diarrhoea
  4. Dyspepsia (indigestion)
  5. Fatigue (feeling of tiredness)
  6. Gastrointestinal pain
  7. Headache (pain in head)
  8. Nausea (feeling of having an urge to vomit)
  9. Oral mucosal blistering (mouth ulcer)
  10. Pain

60+:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Rash
  4. Abdominal pain
  5. Decreased appetite
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Cough
  8. Generalised oedema (swelling all over the body)
  9. Influenza like illness
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 27 people, 79.41%
  2. High Blood Pressure: 4 people, 11.76%
  3. High Blood Cholesterol: 4 people, 11.76%
  4. Leukaemia (blood or bone marrow cancer): 3 people, 8.82%
  5. Stress And Anxiety: 2 people, 5.88%
  6. Blood Potassium Decreased: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Bosulif and Klor-con?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bosulif and Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bosulif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bosulif and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bosutinib and potassium chloride (the active ingredients of Bosulif and Klor-con, respectively), and Bosulif and Klor-con (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: